Enzon Pharma (ENZN) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	7.64M
Short-term investments
Other current assets	270K
Total current assets	7.91M
Property and equipment, net of accumulated depreciation of $39,983 at June 30, 2011 and $38,286 at December 31, 2010
Marketable securities
Other assets
Total assets	11.27M
Accounts payable	770K
Accrued expenses and other	170K
Total current liabilities	940K
Notes payable
Other liabilities
Total liabilities
Commitments and contingencies	0
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2011 and December 31, 2010	0
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 50,631,943 shares at June 30, 2011 and 58,817,561 shares at December 31, 2010	441K
Additional paid-in capital	90.28M
Accumulated other comprehensive income
Accumulated deficit	-80.39M
Total stockholders’ equity	10.33M
Total liabilities and stockholders’ equity	11.27M

Entities mentioned with ENZN

View All Entities